###begin article-title 0
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 73 78 <span type="species:ncbi:9606">Human</span>
HIV-1 Tat Co-Operates with IFN-gamma and TNF-alpha to Increase CXCL10 in Human Astrocytes
###end article-title 0
###begin p 1
Conceived and designed the experiments: RW SB. Performed the experiments: RW HY SB. Analyzed the data: RW NKD SB. Contributed reagents/materials/analysis tools: SB. Wrote the paper: RW SB.
###end p 1
###begin p 2
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 80 83 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 105 108 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 632 637 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 920 925 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-associated neurological disorders (HAND) are estimated to affect 60% of the HIV infected population. HIV-encephalitis (HIVE), the pathological correlate of the most severe form of HAND is often characterized by glial activation, cytokine/chemokine dysregulation, and neuronal damage and loss. However, the severity of HIVE correlates better with glial activation rather than viral load. One of the characteristic features of HIVE is the increased amount of the neurotoxic chemokine, CXCL10. This chemokine can be released from astroglia activated with the pro-inflammatory cytokines IFN-gamma and TNF-alpha, in conjunction with HIV-1 Tat, all of which are elevated in HIVE. In an effort to understand the pathogenesis of HAND, this study was aimed at exploring the regulation of CXCL10 by cellular and viral factors during astrocyte activation. Specifically, the data herein demonstrate that the combined actions of HIV-1 Tat and the pro-inflammatory cytokines, IFN-gamma and TNF-alpha, result in the induction of CXCL10 at both the RNA and protein level. Furthermore, CXCL10 induction was found to be regulated transcriptionally by the activation of the p38, Jnk, and Akt signaling pathways and their downstream transcription factors, NF-kappaB and STAT-1alpha. Since CXCL10 levels are linked to disease severity, understanding its regulation could aid in the development of therapeutic intervention strategies for HAND.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 194 197 194 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Kaul1">[1]</xref>
###xml 199 202 199 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-McArthur1">[2]</xref>
###xml 204 207 204 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Navia1">[3]</xref>
###xml 460 463 460 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Ozdener1">[4]</xref>
###xml 465 468 465 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Giunta1">[5]</xref>
###xml 561 564 561 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Giunta1">[5]</xref>
###xml 624 627 624 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Albright1">[6]</xref>
###xml 789 792 789 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Navia1">[3]</xref>
###xml 64 67 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 170 173 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 247 250 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 365 368 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 445 450 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 451 459 <span type="species:ncbi:9606">patients</span>
###xml 476 484 <span type="species:ncbi:9606">patients</span>
###xml 595 600 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Despite the use of combinatorial anti-retroviral therapy (cART) HIV-associated dementia (HAD), a neurological complication in end stage AIDS, still afflicts 9-11% of the HIV infected population [1], [2], [3]. Even more disturbing is the fact that HIV-associated neurocognitive disorders (HAND), which includes HAD, Minor Cognitive Motor Disorders (MCMD), and other HIV related neuropsychiatric impairments, are estimated to affect almost 60% of HIV-1 patients [4], [5]. These patients are diagnosed by changes in behavior, and cognitive and motor abnormalities [5]. HAD, the most severe form of HIV-1 induced CNS impairment [6], is clinically characterized by motor and behavioral dysfunction that in the absence of therapy may lead to seizures, coma, and death within six months of onset [3].
###end p 4
###begin p 5
###xml 74 77 74 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Kaul1">[1]</xref>
###xml 213 216 213 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-GilgunSherki1">[7]</xref>
###xml 670 673 670 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-GonzalezScarano1">[8]</xref>
###xml 675 678 675 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Minagar1">[9]</xref>
###xml 803 806 803 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-GonzalezScarano1">[8]</xref>
###xml 808 811 808 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Minagar1">[9]</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 227 232 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 233 241 <span type="species:ncbi:9606">patients</span>
###xml 320 323 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 454 457 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV-1 is capable of penetrating the brain shortly after initial infection [1]. However, while cART is able to control the virus in the periphery, the drugs have inferior penetration across the blood brain barrier [7]. So while HIV-1 patients are living longer, they now have to deal with the long term effects of having HIV in the brain. With the increasing prevalence of HAND it is essential to understand the cellular and molecular mechanisms by which HIV exerts its detrimental effects on the CNS. However, since this virus does not infect neurons, the mechanism of neuronal damage and loss seen in HIVE, a pathological correlate of HAD, is not completely understood [8], [9]. Neuronal toxicity is thought to occur, in part, through glial activation and the release of cytotoxic chemokines/cytokines [8], [9], a hallmark feature of HIVE.
###end p 5
###begin p 6
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Kolb1">[10]</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Sui1">[11]</xref>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-vanMarle1">[12]</xref>
###xml 576 580 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Saha1">[13]</xref>
###xml 582 586 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Wesselingh1">[14]</xref>
###xml 588 592 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Wesselingh2">[15]</xref>
###xml 594 598 586 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Brabers1">[16]</xref>
###xml 266 274 <span type="species:ncbi:9606">patients</span>
###xml 510 518 <span type="species:ncbi:9606">patients</span>
Astrocytes are a type of glial cell in the brain capable of releasing neurotoxic chemokines/cytokines after activation by either infection or injury. CXCL10, one of the neurotoxic chemokines released by stimulated astrocytes is up-regulated in the brains and CSF of patients with HIVE and is known to be positively correlated with disease progression [10], [11], [12]. Furthermore, two regulators of CXCL10 expression, IFN-gamma and TNF-alpha, are pro-inflammatory cytokines that are elevated in the brains of patients with HIVE and are also associated with neuropathogenesis [13], [14], [15], [16].
###end p 6
###begin p 7
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Dou1">[17]</xref>
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Wang1">[18]</xref>
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Kutsch1">[19]</xref>
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-vanMarle1">[12]</xref>
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Kutsch1">[19]</xref>
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 143 148 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 204 209 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 643 651 <span type="species:ncbi:9606">patients</span>
Another positive regulator of CXCL10 induction is the HIV-1 protein, Tat [17], [18], [19]. While astrocytes are not productively infected with HIV-1, the provirus in these cells is able to make the early HIV-1 genes, Tat, Rev and Nef [12], [19]. Tat is not only expressed in astrocytes and other productively infected cells like microglia, but it can also be released from these cells to activate other neighboring cells. Kutsch et. al. (2000) has reported that astrocytes activated with Tat have the ability to release CXCL10. Thus, with the increased expression of Tat and the pro-inflammatory cytokines IFN-gamma and TNF-alpha in brains of patients with HIVE, there exists a perfect milieu for exaggerated induction of CXCL10 and the corresponding neuronal damage.
###end p 7
###begin p 8
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Sui1">[11]</xref>
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Sui2">[20]</xref>
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Davis1">[21]</xref>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Sui1">[11]</xref>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Sui2">[20]</xref>
###xml 400 403 400 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-GonzalezScarano1">[8]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Davis1">[21]</xref>
Increased levels of CXCL10 can be damaging to neurons both directly and indirectly [11], [20], [21]. CXCL10 has direct toxic effects by initiating the activation of a calcium-dependent apoptotic pathway in neurons [11], [20]. Indirectly, CXCL10 has the ability to create a chemotactic gradient between the brain and the periphery, allowing T-cells to infiltrate the brain, a hallmark feature of HAND [8], [21]. This T-cell assault not only weakens the blood brain barrier, but increases local inflammation, which can be damaging to the neurons.
###end p 8
###begin p 9
###xml 341 346 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
While both cellular (IFN-gamma and TNF-alpha) and viral (Tat) mediators are known to induce CXCL10, it remains unclear how the interplay of these host and viral factors modulates chemokine expression in astrocytes. The data herein demonstrates the increased induction of CXCL10 at both the RNA and protein level in astrocytes activated with HIV-1 Tat, IFN-gamma, and TNF-alpha. The data also reveals that this increase is regulated transcriptionally by the activation of the p38, Jnk, and Akt signaling pathways and their downstream transcription factors, NF-kappaB and STAT-1alpha. Since CXCL10 levels are linked to disease severity, understanding its regulation could lead to therapeutic intervention strategies for those suffering from HAND.
###end p 9
###begin title 10
Materials and Methods
###end title 10
###begin title 11
Astrocyte cell culture and treatments
###end title 11
###begin p 12
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Davis2">[22]</xref>
###xml 711 715 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Westendorp1">[23]</xref>
###xml 825 829 817 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Andras1">[24]</xref>
###xml 870 878 862 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 907 911 899 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Bonavia1">[25]</xref>
###xml 913 917 905 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Hayashi1">[26]</xref>
###xml 919 923 911 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Oshima1">[27]</xref>
###xml 925 929 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Prendergast1">[28]</xref>
###xml 931 935 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Speth1">[29]</xref>
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 26 29 <span type="species:ncbi:9685">cat</span>
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 400 405 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 503 508 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 577 582 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary human astrocytes (cat# HA1800; ScienCell Research Laboratories, Carlsbad, CA) were prepared as described by the supplier. The human astrocytic cell lines, U-87 and A172 (ATCC; American Type Culture Collection, Manassas, VA), were grown as described previously [22]. The cells (triplicate or quadruplicate wells) were treated for 6-12 hrs (U87/A172) or 24 hours (primary astrocytes), with: 1) HIV-1 Tat (1-72), 2) a combination of the cytokines IFN-gamma (50 ng/ml) and TNF-alpha (5 ng/ml) or 3) HIV-1 Tat and the cytokines. Control treatments included heat inactivated HIV-1 Tat and cells receiving no treatment. The concentration of Tat in the cerebral spinal fluid (CSF) has been reported at 16 ng/ml [23]. However the concentration of Tat in the brain is unknown, though expected to be much higher than in the CSF [24]. The Tat concentration utilized in this in vitro study is generally accepted [25], [26], [27], [28], [29].
###end p 12
###begin p 13
###xml 275 276 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 356 360 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Arai1">[30]</xref>
###xml 362 366 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Dhillon1">[31]</xref>
###xml 368 372 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Lee1">[32]</xref>
###xml 374 378 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-VanWagoner1">[33]</xref>
###xml 380 384 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Yan1">[34]</xref>
The following specific pharmacological inhibitors were used at the final concentration specified: PI3-K Inhibitor LY294002, PLC inhibitor U73122, JAK inhibitor I, JNK inhibitor II, P38 inhibitor SB203580, (all at 10 muM, Calbiochem, Gibbstown, NJ), and NF-kappaB inhibitor N-p-Tosyl-L-phenylalanine chloromethyl ketone (TPCK) (2 muM, Sigma, St. Louis, MO) [30], [31], [32], [33], [34].
###end p 13
###begin title 14
CXCL10 mRNA analysis
###end title 14
###begin p 15
###xml 498 502 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Dhillon2">[35]</xref>
###xml 82 87 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
RNA was extracted from U-87 astrocytes that were either untreated or treated with HIV-1 Tat and/or the cytokines IFN-gamma and TNF-alpha using TRIzol reagent following the treatment periods (Invitrogen Life Technologies). Quantitative analysis of CXCL10 mRNA was done by quantitative Real-Time PCR using the SYBR Green detection method. RT2 PCR primer pair set for CXCL10 was obtained from SuperArray Bioscience and amplification of CXCL10 from first strand cDNA was performed as described earlier [35] using ABI Prism 7700 sequence detector. Data were normalized using Ct values for the house-keeping gene hypoxanthine-guanine phosphoribosyl transferase (HPRT) in each sample. To calculate relative amounts of CXCL10, the average Ct value of the HPRT was subtracted from that for each target gene to provide changes in Ct value. The fold change in gene expression (differences in changes in Ct value) was then determined as log2 relative units.
###end p 15
###begin title 16
Luciferase assay
###end title 16
###begin p 17
###xml 306 310 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Dhillon1">[31]</xref>
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 570 575 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To determine the effects of HIV-1 Tat, IFN-gamma, and TNF-alpha on the transcriptional regulation of CXCL10, astrocytes were transfected with either the Luciferase reporter plasmid, TGL-CXCL10 or a GFP plasmid (Amaxa Biosystems, using a Nucleofector kit (Amaxa Biosystems) and allowed to recover overnight [31]. The transfection efficiency of astrocytes was around 30% as determined by analyzing the number of GFP expressing cells in the GFP reporter plasmid transfected wells. Following recovery the astrocytes transfected with the TGL-CXCL10 plasmid were treated with HIV-1 Tat and the cytokines, IFN-gamma and TNF-alpha. After 12 hours the cells were lysed and Luciferase activity was measured using the Luciferase Reporter Assay System (Promega) according to the manufacturer's instructions. The resulting data was normalized by the protein content in each sample. The data represents results obtained from three independent experiments.
###end p 17
###begin title 18
CXCL10 protein analysis by ELISA
###end title 18
###begin p 19
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 139 144 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Supernatants collected from primary human astrocytes or the astrocytes cell lines U-87 and A172 that were either untreated or treated with HIV-1 Tat and/or cytokines were examined for secreted CXCL10 protein levels using a commercially available CXCL10 ELISA kit (R&D Systems, Minneapolis, MN). The data represents results obtained from three independent experiments.
###end p 19
###begin title 20
Western Blot Analysis
###end title 20
###begin p 21
###xml 696 700 <span type="species:ncbi:9925">goat</span>
###xml 706 711 <span type="species:ncbi:10090">mouse</span>
###xml 712 718 <span type="species:ncbi:9986">rabbit</span>
Treated U-87 cells were lysed using the NE-PER Nuclear and Cytoplasmic Extraction kits (Pierce, Rockford, IL). Equal amounts of the corresponding proteins were electrophoresed in a sodium dodecyl sulfate-polyacrylamide gel (12%) in reducing conditions followed by transfer to PVDF membranes. The blots were blocked with 5% non fat dry milk in phosphate buffered saline. Western blots were then probed with antibodies recognizing the phosphorylated forms of Jnk, Akt, p38, (Cell Signaling, Danvers, MA 1:200), STAT1-alpha (Cell Signaling, 1:500), NF-kappaB p65 (Cell Signaling, 1:1000), and beta-actin (Sigma, St. Louis, MO,1:4000) The secondary antibodies were alkaline phosphatase conjugated to goat anti mouse/rabbit IgG (1:5000). Signals were detected by chemiluminescence (CDP-star; Tropix, Bedford, MA).
###end p 21
###begin title 22
Statistical Analysis
###end title 22
###begin p 23
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
All of the statistical analyses were performed by using a one-tail, independent, Student's t-test. The results were judged as statistically significant at p values</=0.05.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
Up-regulation of CXCL10 mRNA in astrocytes treated with Tat, IFN-gamma and TNF-alpha
###end title 25
###begin p 26
###xml 161 165 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Williams1">[36]</xref>
###xml 424 431 416 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005709-g001">Fig. 1A</xref>
###xml 608 616 592 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005709-g001">Figure 1</xref>
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 222 227 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 829 834 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
It has been previously shown that HIV-1 in conjunction with the pro-inflammatory cytokines IFN-gamma and TNF-alpha can induce expression of CXCL10 in astrocytes [36]. In this study we wanted to dissect the contribution of HIV-1 Tat in this phenomenon. U-87 astrocytes treated with either the cytokines alone or with Tat plus the cytokines show a significant increase in CXCL10 mRNA as early as three hours by Real Time PCR (Fig. 1A). While Tat by itself did not induce CXCL10 mRNA transcription, when combined with IFN-gamma and TNF-alpha, it was capable of eliciting an increase in CXCL10 mRNA. As shown in Figure 1, cells treated with both Tat and the cytokines for just 6 hours demonstrated an almost 4000 fold increase in CXCL10 mRNA as compared with the cells treated with the cytokines alone, thus underscoring the role of HIV-1 Tat in potentiating the transcriptional regulation of CXCL10.
###end p 26
###begin title 27
Tat in combination with IFN-gamma and TNF-alpha increases CXCL10 RNA.
###end title 27
###begin p 28
###xml 174 179 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Real Time PCR analysis showing a significant increase in CXCL10 RNA in U-87 astrocytes treated with a combination of Tat and cytokines. Cells were stimulated with either HIV-1 Tat alone, the cytokines IFN-gamma and TNF-alpha, or Tat and the cytokines together for 6 hour followed by total cell lysis and RNA extraction. (B) Luciferase assay demonstrating the ability of Tat in combination with the cytokines to transcriptionally regulate the CXCL10 gene. The induction of CXCL10 is dependent upon the binding of the ISRE and IkappaB regulatory sequences. The data represents the mean+/-SD from three independent experiments (*, p<0.05, ***, p<0.001).
###end p 28
###begin p 29
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Dhillon1">[31]</xref>
###xml 538 545 530 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005709-g001">Fig. 1B</xref>
###xml 251 256 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To confirm the role of Tat in the transcriptional regulation of CXCL10, we performed luciferase reporter assays utilizing the TGL-CXCL10 plasmid [31]. Briefly, U-87 cells were transfected with a TGL-CXCL10 plasmid followed by a 12 hour treatment with HIV-1 Tat and the cytokines, IFN-gamma and TNF-alpha. There was a significant increase in luciferase expression in the cells exposed to both Tat and the cytokines, as compared with cells treated with the cytokines alone, thereby confirming a role for Tat in the transcription of CXCL10 (Fig. 1B). Furthermore, when the U-87 astrocytes were transfected with the TGL-CXCL10 plasmid containing a mutated IFN-stimulated response element (ISRE) or a mutated kappaB binding site followed by treatment with Tat plus the cytokines, there was little to no luciferase detected above negative control levels. These data thus suggest that Tat in combination with the cytokines can strongly activate the CXCL10 gene, and this activation is highly dependent on the occupancy of the two key regulatory sequences, ISRE and kappaB.
###end p 29
###begin title 30
CXCL10 protein expression is increased in the presence of Tat and the cytokines
###end title 30
###begin p 31
###xml 255 263 255 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005709-g002">Figure 2</xref>
###xml 154 159 <span type="species:ncbi:9606">human</span>
###xml 621 626 <span type="species:ncbi:9606">human</span>
###xml 871 876 <span type="species:ncbi:9606">human</span>
To confirm that the increase in CXCL10 RNA correlated with an increase in CXCL10 protein, supernatants from U-87 astrocytes, A172 astrocytes, and primary human astrocytes were collected and analyzed for CXCL10 expression using an ELISA assay. As shown in Figure 2 and similar to the mRNA study, in both the astrocyte cell lines, Tat by itself was unable to induce CXCL10 expression. Similarly to the RNA studies, Tat in combination with IFN-gamma and TNF-alpha, exerted a 2 fold increase in CXCL10 protein levels over that of levels from cells treated with only the cytokine mix. This phenomenon was confirmed in primary human astrocytes and, similar to findings in cell lines, Tat in conjunction with the cytokines resulted in a 2 fold increase in CXCL10 expression over that of the cytokines by themselves. Similar findings in both the cell lines as well as in primary human astrocytes lend credence to the important role of Tat in potentiating cytokine-mediated up-regulation of CXCL10.
###end p 31
###begin title 32
Tat in combination with IFN-gamma and TNF-alpha increases CXCL10 protein.
###end title 32
###begin p 33
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 124 129 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 367 372 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Increased CXCL10 protein expression in (A) primary human astrocytes or (B) U-87 and A172 astrocytes cell lines treated with HIV-1 Tat alone, the cytokines IFN-gamma and TNF-alpha, or Tat and the cytokines together for 24 and 12 hours respectively. Both primary and cell line astrocytes showed a significant increase in CXCL10 protein levels in the cells treated with HIV-1 Tat and the cytokines, than with either treatment alone. Treatment of U-87 and A172 cells with heat inactivated (HI) Tat in conjunction with the cytokines did not lead to an increase in CXCL10 protein levels compared with cells treated with the cytokines alone. The data represents the mean+/-SD from three independent experiments (**, p<0.01, ***, p<0.001).
###end p 33
###begin title 34
Tat enhances activation of IFN-gamma/TNF-alpha signaling pathways involved in CXCL10 regulation
###end title 34
###begin p 35
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Means1">[37]</xref>
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Park1">[38]</xref>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Popik1">[39]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Shapiro1">[40]</xref>
###xml 780 789 764 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005709-g003">Figure 3A</xref>
###xml 264 269 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Past studies have demonstrated that mitogen activated protein kinase (MAPK) activation is critical in regulating inflammatory responses such as cytokine/chemokine expression in response to multiple stimuli [37], [38], [39], [40]. We next sought to explore whether HIV-1 Tat could potentiate the existing signaling pathways used by IFN-gamma and TNF-alpha. U-87 astrocytes were treated with Tat alone, the cytokines IFN-gamma and TNF-alpha alone, or a mixture of Tat and the cytokines for 30 min. This time point was chosen based on the time-dependent activation of p38, Jnk, and Akt in astrocytes treated with Tat and the cytokines, where 30 min post-treatment was the optimal time for enhanced phosphorylation as determined by Western blot analysis (data not shown). As shown in Figure 3A there was an increase in the activation of Jnk, p38, and Akt in cells treated with the combination of Tat and cytokines compared with cells exposed to either treatment alone. In each instance, as expected each of the cytokine was able to induce phosphorylation of each of the pathways. While Tat was able to mediate only a modest activation of these pathways by itself, in the presence of cytokines, it potentiated a robust activation of these pathways as compared with the cytokines by themselves. These data demonstrate the ability of Tat to enhance signaling pathways activated by other pro-inflammatory molecules, thereby resulting in an increased expression of the target gene CXCL10.
###end p 35
###begin title 36
The p38, Jnk, and Akt signaling pathways mediate CXCL10 induction in stimulated U-87 astrocytes.
###end title 36
###begin p 37
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A) Western Blot analysis of cytosolic lysates collected from cells untreated, HIV-1 Tat treated, IFN-gamma and TNF-alpha treated, or treated with Tat in combination with the cytokines for 30 min. The blots were probed with antibodies against phospho-p38, phospho-Jnk, and phosphor-Akt. An antibody against beta-actin was used to reprobe the blots for normalization. B), C) and D) Densitometric scans illustrating the ratio of phospho-p38, Jnk, and Akt to beta-actin levels. E) Activation of these pathways was shown to be involved in the increased expression of CXCL10 through inhibition of the p38 pathway by SB203580, the Jnk pathway by Jnk II inhibitor, and the Akt pathway by LY294002. Inhibition of the PLC-gamma pathway by U73122 had no effect on CXCL10 protein levels. The data represents the mean+/-SD from three independent experiments (*, p<0.05, **, p<0.01, ***, p<0.001).
###end p 37
###begin p 38
###xml 353 360 352 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005709-g003">Fig. 3E</xref>
The roles of Jnk, p38, and Akt activation in CXCL10 induction were further examined using a pharmacological approach. U-87 astrocytes were pretreated with either the Jnk II inhibitor, the P38 inhibitor SB203580, or the PI3-K Inhibitor LY294002, all at a concentration of 10 muM, followed by stimulation of cells with Tat and the cytokine mix for 6 hrs (Fig. 3E). Supernatants from treated cells were collected and analyzed for CXCL10 content by ELISA. Pre-treatment of the astrocytes with the Jnk, p38, and Akt inhibitors followed by stimulation with Tat and cytokines resulted in significant reduction of CXCL10, thus underscoring the role of these signaling pathways in the induction of CXCL10.
###end p 38
###begin title 39
Role of transcription factors NF-kappaB and STAT-1alpha in induction of CXCL10
###end title 39
###begin p 40
###xml 94 97 86 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Giunta1">[5]</xref>
###xml 99 103 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Majumder1">[41]</xref>
###xml 105 109 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Majumder2">[42]</xref>
###xml 111 115 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-CroitoruLamoury1">[43]</xref>
###xml 117 121 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Ohmori1">[44]</xref>
###xml 123 127 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Ohmori2">[45]</xref>
###xml 616 620 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Majumder1">[41]</xref>
###xml 622 626 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Majumder2">[42]</xref>
The transcription factors NF-kappaB and STAT-1alpha play key roles in the induction of CXCL10 [5], [41], [42], [43], [44], [45]. Both of these transcription factors mediate CXCL10 regulation by binding to specific regulatory sequences in the promoter region, the ISRE site for STAT-1alpha and the kappaB1 and kappaB2 sites for NF-kappaB. Binding of both NF-kappaB and STAT-1alpha is necessary for the synergistic increase in CXCL10 mRNA/protein. IFN-gamma and TNF-alpha, through their respective signaling pathways and subsequent activation of NF-kappaB and STAT-1alpha, are known to synergistically increase CXCL10 [41], [42]. Therefore, U8-7 cells were treated with either Tat or the cytokines, or Tat in conjunction with the cytokines for 60 min followed by cell lysis and isolation of nuclear proteins. Nuclear extracts were subsequently analyzed for p65-NF-kappaB and pSTAT-1alpha content by Western Blot analysis.
###end p 40
###begin p 41
###xml 19 28 19 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005709-g004">Figure 4A</xref>
###xml 502 509 472 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005709-g004">Fig. 4D</xref>
As demonstrated in Figure 4A the ability of Tat to enhance IFN-gamma/TNF-alpha signaling directly correlates with an increase in the phosphorylation/activation of NF-kappaB and STAT-1alpha. To link the increased activation of NF-kappaB and STAT-1alpha to CXCL10 regulation, U-87 cells were pretreated with the inhibitors specific for NF-kappaB (TPCK at 2 muM) or JAK I (JAK I inhibitor at 10 muM) followed by stimulation of cells with Tat and cytokine mix and analyzed for CXCL10 by ELISA. As shown in Fig. 4D inhibition of both NF-kappaB and STAT-1 resulted in a significant and remarkable reduction in CXCL10 expression in astrocytes, thereby confirming the role of these factors in viral and cytokine-mediated synergistic induction of CXCL10.
###end p 41
###begin title 42
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
STAT-1alpha and NF-kappaB play a role in the increased induction of CXCL10 by HIV-1 Tat and the cytokines in U-87 astrocytes.
###end title 42
###begin p 43
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A) Western Blot analysis of nuclear lysates collected from cells untreated, HIV-1 Tat treated, IFN-gamma and TNF-alpha treated, or treated with Tat in combination with the cytokines for 60 min. The blots were probed with antibodies against phospho-NF-kappaB p65 and phospho-STAT-1alpha. Antibodies against beta-actin were used to reprobe the blots for normalization. B), C) Densitometric scans illustrating the ratio of phospho-NF-kappaB p65 and phospho-STAT-1alpha to beta-actin levels. E) Activation of these transcription factors was shown to be involved in the increased expression of CXCL10 through inhibition of the NF-kappaB by TPCK and the inhibition of the Jak/STAT pathway by a Jak I inhibitor. The data represents the mean+/-SD from three independent experiments (***, p<0.001).
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Asensio1">[46]</xref>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Miller1">[47]</xref>
###xml 684 688 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Luster1">[48]</xref>
###xml 690 694 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Luster2">[49]</xref>
###xml 856 860 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Majumder2">[42]</xref>
###xml 980 984 968 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-vanMarle1">[12]</xref>
###xml 986 990 974 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Kutsch1">[19]</xref>
###xml 992 996 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Asensio2">[50]</xref>
###xml 956 961 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Up-regulated expression of chemokines in the brain has been recognized as an important correlate of various neurodegenerative diseases and related neuroinflammation. Chemokines and their receptors are expressed by a wide variety of cells, including those intrinsic to the CNS. These proteins can regulate inflammatory responses by recruiting lymphocytes and monocytes/macrophages to areas of inflammation within the brain contributing to the injury and eventual loss of neurons [46], [47]. Cerebral expression of various chemokines and their receptors is increased in HIVE. CXCL10 was first identified as an early response gene induced after IFN-gamma treatment in a variety of cells [48], [49]. Interactions of soluble host factors, such as those between IFN-gamma and TNF-alpha, have been shown to synergistically induce the expression of this chemokine [42]. In addition to its induction by host factors, CXCL10 can also be induced independently by the HIV-1 viral protein Tat [12], [19], [50].
###end p 45
###begin p 46
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Kolb1">[10]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-vanMarle1">[12]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Sanders1">[51]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Kolb1">[10]</xref>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Sui1">[11]</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Sui2">[20]</xref>
###xml 88 93 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
Increased levels of CXCL10 have been detected in the CSF and plasma of individuals with HIV-1 infection [10]. Additionally, brain tissue derived from patients with HAD also reveal increased expression of mRNA for CXCL10 and this expression can be localized to astrocytes [12], [51]. Levels of this neurotoxic chemokine are positively correlated with HAD disease progression [10]. Additionally, up-regulated expression of CXCL10 and its neurotoxic role has also been previously demonstrated in SHIV-infected macaque brains with lentiviral lesions [11], [20].
###end p 46
###begin p 47
###xml 502 506 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Saha1">[13]</xref>
###xml 508 512 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Brabers1">[16]</xref>
###xml 599 603 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Saha1">[13]</xref>
###xml 605 609 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Wesselingh1">[14]</xref>
###xml 611 615 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Wesselingh2">[15]</xref>
###xml 617 621 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Brabers1">[16]</xref>
###xml 623 627 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Gelbard1">[52]</xref>
###xml 629 633 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Tyor1">[53]</xref>
###xml 723 727 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Brabers1">[16]</xref>
###xml 729 733 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Hurwitz1">[54]</xref>
###xml 884 888 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Saha1">[13]</xref>
###xml 890 894 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Brabers1">[16]</xref>
###xml 896 900 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Majumder2">[42]</xref>
###xml 902 906 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Ohmori2">[45]</xref>
###xml 908 912 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Chao1">[55]</xref>
###xml 914 918 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Paludan1">[56]</xref>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 142 147 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 496 501 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In the current study we sought to explore the regulation of CXCL10 in human astrocytes stimulated with a mixture of IFN-gamma, TNF-alpha, and HIV-1 Tat. The rationale for using three different stimulants was based on the premise that several host immune and viral factors have the potential to interact during HAD, resulting in neuronal damage and loss. The pro-inflammatory cytokine TNF-alpha was chosen because it is a key cytokine produced by activated astrocytes and microglia in response to HIV-1 [13], [16]. Levels of this cytokine are also known to positively correlate with HAD pathogenesis [13], [14], [15], [16], [52], [53]. Furthermore, TNF-alpha has the ability of not only inducing CXCL10 expression by itself [16], [54], but also synergistically with various other host factors, such as IFN-gamma, thus increasing the toxicity and inflammation in the surrounding milieu [13], [16], [42], [45], [55], [56].
###end p 47
###begin p 48
###xml 159 163 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Majumder2">[42]</xref>
###xml 165 169 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Ohmori2">[45]</xref>
###xml 355 359 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Majumder2">[42]</xref>
###xml 361 365 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Luster1">[48]</xref>
###xml 367 371 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Luster2">[49]</xref>
###xml 542 546 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Shapshak1">[57]</xref>
###xml 459 464 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
One of the well-studied host factors that has been shown to co-operatively interact with TNF-alpha to induce CXCL10 is the pro-inflammatory cytokine IFN-gamma [42], [45]. Therefore IFN-gamma was also chosen as an additional stimulant in the present study. IFN-gamma is a known inducer for the expression CXCL10 in several cell types, including astrocytes [42], [48], [49]. Additionally, IFN-gamma has been shown to be markedly increased in CNS tissues during HIV-1 infection in the brain and has been implicated in the pathophysiology of HAD [57].
###end p 48
###begin p 49
###xml 638 642 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-vanMarle1">[12]</xref>
###xml 644 648 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Kutsch1">[19]</xref>
###xml 650 654 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Asensio2">[50]</xref>
###xml 673 680 665 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005709-g002">Fig. 2A</xref>
###xml 823 830 815 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005709-g001">Figs 1A</xref>
###xml 835 843 827 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005709-g002">2A and B</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 117 122 <span type="species:ncbi:9606">human</span>
###xml 364 369 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 662 667 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 854 859 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 in combination with IFN-gamma and TNF-alpha has been shown to synergistically up-regulate CXCL10 expression in human astrocytes. However, which viral protein contributes to this effect remains poorly understood. In our attempts to dissect the role of known viral toxins involved in cytokine-mediated induction of CXCL10, we initially examined the effects of HIV-1 Nef, the envelope protein gp120, and Tat in conjunction with the cytokine mix for their ability to up-regulate CXCL10 in U-87 astrocytes. The rationale for selecting these viral toxins stems from their expression in astrocytes and their ability to activate astrocytes [12], [19], [50]. Since HIV-1 Tat (Fig. 2A) but not gp120 or Nef (data not shown) demonstrated the most significant increase with the cytokines in inducing both CXCL10 RNA and protein (Figs 1A and 2A and B), we used HIV-1 Tat for our further studies.
###end p 49
###begin p 50
###xml 523 527 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Ohmori1">[44]</xref>
###xml 529 533 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Ohmori2">[45]</xref>
###xml 535 539 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Darnell1">[58]</xref>
Increased induction of CXCL10 RNA in astrocytes was mediated via transcriptional regulation as demonstrated by transfection of promoter constructs linked to luciferase reporter gene. Using these assays it was demonstrated that combinatorial treatment of astrocytes with the viral and host factors resulted in increased transcription of the luciferase gene. Promoter constructs with mutations in the ISRE (STAT-1alpha) binding site or IkB (NF-kappaB) binding sites, the two major regulatory sequences in the CXCL10 promoter [44], [45], [58], however, resulted in abrogation of luciferase expression, thus underscoring the role of each of these binding sites in the induction of CXCL10.
###end p 50
###begin p 51
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Williams1">[36]</xref>
###xml 802 806 802 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Chong1">[59]</xref>
###xml 808 812 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Kolson1">[60]</xref>
###xml 814 818 814 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Zhao1">[61]</xref>
###xml 252 257 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Exploration of the signaling pathways critical for the increased induction of CXCL10 in astrocytes suggested the involvement of the Jnk, p38, and Akt pathways. These findings are in agreement with the synergistic induction of CXCL10 mediated by intact HIV-1 virus and the cytokine mix as reported earlier [36]. In each of the three pathways (Jnk, p38, and Akt) there was modest activation by Tat alone, and definitive activation by the cytokines themselves, however, in the presence of all the three stimulants there was a significant activation of each of these pathways, more so than with either treatment alone. Confirmation of these pathways using specific pharmacological inhibitors further indicated their involvement in the regulation of CXCL10 expression. Activation of the survival factor Akt [59], [60], [61] in the presence of viral and host factors leads us to speculate that this could be a mechanism by the virus to hijack the host machinery in order to maintain a long term reservoir of the neurotoxic inflammatory mediators, including CXCL10. It should be pointed out that inhibition of one specific signaling pathway or transcription factor never completely abrogated the expression of CXCL10, thus indicating involvement of parallel signaling pathways and transcription factors that could be working in unison.
###end p 51
###begin p 52
###xml 193 197 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Majumder1">[41]</xref>
###xml 374 378 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Williams1">[36]</xref>
###xml 380 384 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Bach1">[62]</xref>
###xml 386 390 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Conant1">[63]</xref>
###xml 392 396 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Lawrence1">[64]</xref>
###xml 398 402 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Schutze1">[65]</xref>
###xml 404 408 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Sheng1">[66]</xref>
###xml 263 268 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
All three pathways (Jnk, p38 and Akt) once activated, can in turn activate the downstream transcription factor NF-kappaB, which has two separate, yet vital binding sites on the CXCL10 promoter [41]. Multiple studies have demonstrated that astrocytes activated by HIV-1/viral proteins have increased nuclear translocation and activation of the transcription factor NF-kappaB [36], [62], [63], [64], [65], [66], which, in turn, can regulate CXCL10 expression. In the present study we demonstrate that exposure of astrocytes to Tat and the cytokines results in increased activation and nuclear translocation of the p65 subunit of NF-kappaB compared with cells treated with either the viral or cellular stimuli. Since Jnk, p38, and Akt all have the ability to activate NF-kappaB, their convergence on NF-kappaB could lead to a dramatic increase in CXCL10 induction. In fact, when NF-kappaB was pharmacologically inhibited, there was a significant inhibition of CXCL10 expression.
###end p 52
###begin p 53
###xml 629 633 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-Lawrence1">[64]</xref>
###xml 892 896 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005709-TurchanCholewo1">[67]</xref>
While activation of NF-kappaB can be attributed to all the three stimuli in astrocytes, STAT-1alpha activation is unique to IFN-gamma or IFN-gamma plus TNF-alpha. Intriguingly, our data indicated significant activation of STAT-1alpha in astrocytes treated with all three stimuli and this was further confirmed using the JAK I specific inhibitor, resulting in a dramatic decrease also in CXCL10 expression. Since Tat does not bind to a known cell receptor, and instead acts by diffusing through the cell membrane, it should be noted that while Tat activation of MAPK signaling pathways and transcription factors has been reported [64], there is a paucity of information of how Tat actually activates these proteins. Recent studies point to the role of Tat-mediated activation of NADPH oxidase, a membrane protein, as a key upstream player involved in the activation of MAPK signaling pathways [67]. It is thus likely that the activation of NADPH oxidase could explain the ability of Tat to activate Jnk, p38, Akt and their downstream transcription factors NF-kappaB and STAT-1alpha. Further studies exploring the role of NADPH oxidase in this process are warranted.
###end p 53
###begin p 54
###xml 428 436 416 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005709-g005">Figure 5</xref>
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 162 167 <span type="species:ncbi:9606">human</span>
In conclusion, we have provided evidence that HIV-1 Tat in conjunction with the cytokines, IFN-gamma and TNF-alpha, is capable of regulating CXCL10 expression in human astrocytes at both the RNA and protein levels. This regulation is likely due to the activation of the Jnk, p38, and Akt signaling pathways and activation of their downstream transcription factors NF-kappaB and STAT-1 as demonstrated in an overall schematic in Figure 5.
###end p 54
###begin title 55
###xml 112 117 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Schematic of the signaling pathways involved in the increased induction of CXCL10 in astrocytes stimulated with HIV-1 Tat in conjunction with IFN-gamma and TNF-alpha.
###end title 55
###begin p 56
The major signaling pathways activated include p38, Jnk, and Akt, which are able to converge on NF-kappaB. The activation of NF-kappaB, along with the activation of STAT-1alpha, results in the transcription of CXCL10.
###end p 56
###begin p 57
Given that the neuronal toxicity in HAD is thought to occur through glial activation and the release of cytotoxic chemokines/cytokines, dissecting the complex interplay between host factors and viral proteins can lead to a better understanding of disease pathogenesis. The ability of Tat to potentiate activation of signaling pathways stimulated by IFN-gamma and TNF-alpha is an ingenious approach by the virus to exploit the activated cells into generating reservoirs of pro-inflammatory factors, such as CXCL10. This in turn could aid in perpetuating activation, infection, and destruction of several other cell types in the CNS.
###end p 57
###begin p 58
Since excessive amounts of CXCL10 can be neurotoxic, our findings lend further credence to the role of CXCL10 in progression of AIDS-associated dementia. The consequences of CXCL10 over expression not only include enhanced influx of inflammatory cells into the CNS, but also amplification of neuronal dysfunction/death in end-stage HAD. Since CXCL10 levels are linked to disease severity, understanding its regulation could aid in the development of therapeutic intervention strategies for HAND.
###end p 58
###begin p 59
###xml 120 125 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We would like to thank Dr. Avindra Nath (Department of Neurology, Johns Hopkins University for generously providing the HIV-1 Tat (1-72). We acknowledge the technical assistance of Shannon Callen in the preparation of this manuscript.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mechanisms of neuronal injury and death in HIV-1 associated dementia.
###end article-title 61
###begin article-title 62
###xml 0 28 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
Human immunodeficiency virus-associated dementia.
###end article-title 62
###begin article-title 63
The AIDS dementia complex: II. Neuropathology.
###end article-title 63
###begin article-title 64
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Molecular mechanisms of HIV-1 associated neurodegeneration.
###end article-title 64
###begin article-title 65
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 149 152 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.
###end article-title 65
###begin article-title 66
###xml 16 44 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Pathogenesis of human immunodeficiency virus-induced neurological disease.
###end article-title 66
###begin article-title 67
Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier.
###end article-title 67
###begin article-title 68
The neuropathogenesis of AIDS.
###end article-title 68
###begin article-title 69
###xml 99 102 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis.
###end article-title 69
###begin article-title 70
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10.
###end article-title 70
###begin article-title 71
CXCL10-induced cell death in neurons: role of calcium dysregulation.
###end article-title 71
###begin article-title 72
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10.
###end article-title 72
###begin article-title 73
###xml 80 83 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia.
###end article-title 73
###begin article-title 74
###xml 80 83 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry.
###end article-title 74
###begin article-title 75
Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia.
###end article-title 75
###begin article-title 76
###xml 65 68 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia.
###end article-title 76
###begin article-title 77
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 87 93 <span type="species:ncbi:10090">murine</span>
Neuropathologic and neuroinflammatory activities of HIV-1-infected human astrocytes in murine brain.
###end article-title 77
###begin article-title 78
###xml 11 46 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis.
###end article-title 78
###begin article-title 79
###xml 55 90 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes.
###end article-title 79
###begin article-title 80
###xml 66 94 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis.
###end article-title 80
###begin article-title 81
###xml 63 68 <span type="species:ncbi:9606">human</span>
Chronic ethanol inhibits CXC chemokine ligand 10 production in human A172 astroglia and astroglial-mediated leukocyte chemotaxis.
###end article-title 81
###begin article-title 82
###xml 74 79 <span type="species:ncbi:9606">human</span>
Ethanol-induced modulation of inducible nitric-oxide synthase activity in human A172 astrocytoma cells.
###end article-title 82
###begin article-title 83
###xml 55 60 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.
###end article-title 83
###begin article-title 84
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells.
###end article-title 84
###begin article-title 85
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 72 75 <span type="species:ncbi:10116">rat</span>
HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons.
###end article-title 85
###begin article-title 86
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier.
###end article-title 86
###begin article-title 87
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogen-activated protein kinase-dependent pathways.
###end article-title 87
###begin article-title 88
###xml 26 54 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor.
###end article-title 88
###begin article-title 89
###xml 13 41 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons.
###end article-title 89
###begin article-title 90
###xml 100 103 <span type="species:ncbi:10116">rat</span>
Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes.
###end article-title 90
###begin article-title 91
###xml 116 119 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
PDGF synergistically enhances IFN-gamma-induced expression of CXCL10 in blood-derived macrophages: implications for HIV dementia.
###end article-title 91
###begin article-title 92
ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways.
###end article-title 92
###begin article-title 93
Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.
###end article-title 93
###begin article-title 94
###xml 98 101 <span type="species:ncbi:10116">rat</span>
The role of TNF-alpha and its receptors in the production of Src-suppressed C kinase substrate by rat primary type-2 astrocytes.
###end article-title 94
###begin article-title 95
Bleomycin treatment causes enhancement of virus replication in the lungs of SHIV-infected macaques.
###end article-title 95
###begin article-title 96
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes.
###end article-title 96
###begin article-title 97
Activation of TNF-alpha transcription utilizes distinct MAP kinase pathways in different macrophage populations.
###end article-title 97
###begin article-title 98
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes.
###end article-title 98
###begin article-title 99
###xml 11 46 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway.
###end article-title 99
###begin article-title 100
###xml 48 51 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro.
###end article-title 100
###begin article-title 101
###xml 14 19 <span type="species:ncbi:9606">human</span>
Regulation of human IP-10 gene expression in astrocytoma cells by inflammatory cytokines.
###end article-title 101
###begin article-title 102
p48/STAT-1alpha-containing complexes play a predominant role in induction of IFN-gamma-inducible protein, 10 kDa (IP-10) by IFN-gamma alone or in synergy with TNF-alpha.
###end article-title 102
###begin article-title 103
###xml 48 53 <span type="species:ncbi:9606">human</span>
Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation.
###end article-title 103
###begin article-title 104
###xml 180 186 <span type="species:ncbi:10090">murine</span>
Cooperative interaction between interferon (IFN) stimulus response element and kappa B sequence motifs controls IFN gamma- and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter.
###end article-title 104
###begin article-title 105
###xml 95 101 <span type="species:ncbi:10090">murine</span>
The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha.
###end article-title 105
###begin article-title 106
Chemokines in the CNS: plurifunctional mediators in diverse states.
###end article-title 106
###begin article-title 107
AIDS and the brain: is there a chemokine connection?
###end article-title 107
###begin article-title 108
Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).
###end article-title 108
###begin article-title 109
Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.
###end article-title 109
###begin article-title 110
###xml 24 59 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.
###end article-title 110
###begin article-title 111
###xml 28 31 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Chemokines and receptors in HIV encephalitis.
###end article-title 111
###begin article-title 112
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Neuroprotective strategies for HIV-1-associated neurologic disease.
###end article-title 112
###begin article-title 113
Cytokine expression in the brain during the acquired immunodeficiency syndrome.
###end article-title 113
###begin article-title 114
Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1.
###end article-title 114
###begin article-title 115
Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors.
###end article-title 115
###begin article-title 116
Synergistic action of pro-inflammatory agents: cellular and molecular aspects.
###end article-title 116
###begin article-title 117
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Elevated expression of IFN-gamma in the HIV-1 infected brain.
###end article-title 117
###begin article-title 118
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.
###end article-title 118
###begin article-title 119
Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.
###end article-title 119
###begin article-title 120
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Neuropathogenesis of central nervous system HIV-1 infection.
###end article-title 120
###begin article-title 121
Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke.
###end article-title 121
###begin article-title 122
The IFN gamma receptor: a paradigm for cytokine receptor signaling.
###end article-title 122
###begin article-title 123
###xml 14 49 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 161 166 <span type="species:ncbi:9606">human</span>
Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes.
###end article-title 123
###begin article-title 124
###xml 102 107 <span type="species:ncbi:9606">human</span>
Astrocyte differentiation selectively upregulates CCL2/monocyte chemoattractant protein-1 in cultured human brain-derived progenitor cells.
###end article-title 124
###begin article-title 125
TNF-induced activation of NF-kappa B.
###end article-title 125
###begin article-title 126
###xml 17 22 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 91 96 <span type="species:ncbi:9606">human</span>
U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes.
###end article-title 126
###begin article-title 127
###xml 99 102 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat.
###end article-title 127
###begin p 128
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 128
###begin p 129
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by funding from MH62969, MH068212, DA023397, DA020392, DA024442, RR016443 (SB), and F31NS062665 (RW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 129

